Open-angle Glaucoma

• FDA label_change · 2021-06-22
  FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for brinzolamide by Sandoz Inc. to update the product labeling. The update may reflect changes to in…

• FDA label_change · 2020-04-02
  FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for TRAVATAN Z (travoprost) from Novartis Pharmaceuticals Corporation, resulting in a labeling c…

• FDA label_change · 2017-09-22
  FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for TRAVATAN Z (travoprost) from Novartis Pharmaceuticals Corporation, resulting in updated labe…

• FDA label_change · 2016-01-20
  FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)

  FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) submitted by Alcon Laboratories, Inc., resulting i…

• FDA label_change · 2016-01-15
  FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)

  The FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) to update the product labeling.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2015-10-20
  FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)

  FDA granted a supplemental approval for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb, updating the product labeling per the supplemental…

• FDA label_change · 2011-09-07
  FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for TRAVATAN Z (travoprost) submitted by Novartis Pharmaceuticals, updating the product labeling…